Pharmacists have admirably navigated the changes to the provision of the Opioid Therapy Program (OTP) in 2023, overcoming numerous challenges whilst maintaining uninterrupted service to
Psychostimulant changes The PDL Professional Officers would like to bring to the attention of NSW pharmacists some recent regulatory changes regarding the requirements to prescribe
Pharmacists have limited time left to register their interest in their pharmacy taking part in the NSW Pharmacy Trial, with the expression of interest process
The NSW Government-sponsored Pharmacy Trial for the extended supply of oral contraceptive pills (OCPs) by community pharmacists commenced on 27 September 2023. The trial aims
The PDL Professional Officers have been made aware of a situation where a person approaches dispensary staff and introduces themselves as a representative from a
The NSW Government-sponsored clinical trial for the management of urinary tract infections (UTIs) by community pharmacists was expanded on 31 July 2023 to include more
The Pharmacy Stakeholder Forum is a joint initiative between the Pharmacy Council of NSW, NSW Health and other pharmacy organisations representing most NSW pharmacists. You
As NSW pharmacists may be aware, NSW Health has announced the NSW Government-sponsored clinical trial for the management of urinary tract infections (UTIs) by community
The Pharmacy Stakeholder Forum is a joint initiative between the Pharmacy Council of NSW, the NSW Ministry of Health and other pharmacy organisations representing most
PDL would like to remind NSW-based pharmacists and pharmacy owners of the requirement to complete an S8 stock check during March. While most pharmacists are